Parlamento aplaza acuerdo de OMC sobre PI y Salud Pública hasta que la UE dé un impulso al acceso bilateral a medicamentos 19/07/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Por David Cronin para Intellectual Property Watch Los miembros del Parlamento Europeo han decidido aplazar la aceptación del protocolo a un acuerdo de la Organización Mundial del Comercio en materia de patentes sobre medicamentos, a la espera de que los gobiernos de la Unión Europea otorguen un mayor respaldo político y financiero a los países […]
Parliament Delays WTO IP Health Deal Till EU Boosts Bilateral Drug Access 12/07/2007 by David Cronin for Intellectual Property Watch Leave a Comment By David Cronin for Intellectual Property Watch Members of the European Parliament (MEPs) have voted to delay approval of a World Trade Organization agreement on patents for medicines, pending European Union governments giving greater political and financial support to poor countries seeking to boost the supply of affordable drugs. The 785-strong Parliament adopted a resolution […]
OECD Meeting Highlights New Drug Purchasing Model Despite NGO Doubts 27/06/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment By Tove Iren S. Gerhardsen A recent Organisation of Economic Cooperation and Development (OECD) high-level meeting on boosting the development of medicines for neglected diseases mainly found in developing countries, focused on a new model under which governments promise up-front to buy a certain medicine once it has been developed. The Advance Market Commitments (AMC) […]
OECD High-Level Meeting On Neglected Diseases Agrees On Agenda For Action 22/06/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch 2 Comments By Tove Iren S. Gerhardsen NOORDWIJK, THE NETHERLANDS – Participants at a high-level meeting of the Organisation for Economic Cooperation and Development (OECD) meeting here informally agreed on an agenda for what needs to be done in the area of neglected diseases, and although no specific commitments were made, participants said the outcome is a […]
WIPO Development Meeting Side-Events Held On Patents, Competition, Implementation 19/06/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment By Tove Iren S. Gerhardsen Side-events were held by a non-governmental organisation (NGO), an intergovernmental organisation and the Canadian competition authority last week alongside the negotiations for a Development Agenda at the World Intellectual Property Organization. They focused on implementation of such an agenda in developing countries, the relationship between intellectual property rights and competition […]
Regulators Wrestle With Data Exclusivity For Pharmaceuticals Worldwide 18/06/2007 by Tatum Anderson for Intellectual Property Watch Leave a Comment By Tatum Anderson for Intellectual Property Watch A debate over how long to give exclusive rights over data submitted by pharmaceutical companies to governments in order to receive approval to sell a drug in their markets is controversial not only in India, but worldwide.
Imperfect Compromise Seen In India Data Exclusivity Report 18/06/2007 by Tatum Anderson for Intellectual Property Watch Leave a Comment By Tatum Anderson for Intellectual Property Watch When the Indian government published its report recently on yet another pharmaceutical patent-related issue predicted to split the industry, the Indian newspapers were divided as to whether brand name producers, generics producers or public health advocates had won. The reason for the confusion is that the report is an exercise in appeasement, said Shamnad Basheer, a law professor at George Washington University Law School, and expert on this latest controversial subject, called data exclusivity, which is the rights drugs producers have over the data used to obtain marketing approval in a country.
Novartis Case Against India’s Patent Law Resumes This Week 18/06/2007 by Tatum Anderson for Intellectual Property Watch 1 Comment By Tatum Anderson for Intellectual Property Watch The latest chapter in the Swiss pharmaceutical company Novartis’ challenge to the Indian intellectual property system begins on 18 June when the Indian Patent and Trademark Appellate Board (IPAB) is scheduled to hold its first hearing. However, lawyers expect “teething” problems to delay the proceedings. Although the IPAB […]
WIPO Development Agenda Meeting Snags On Norm-Setting 14/06/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment By Tove Iren S. Gerhardsen World Intellectual Property Organization (WIPO) members this week are engaged in intensive negotiations on proposals to change WIPO’s activities and mandate to include more development issues. The Group B of developed countries, particularly the United States, has taken a hard line against proposals relating to flexibilities in World Trade Organization […]
G8 Summit Agrees On Africa Declaration With Weakened TRIPS Language 08/06/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment By Tove Iren S. Gerhardsen The Group of Eight (G8) final declaration on “growth and responsibility” in Africa is being met with initial reactions from observers that it contains a weaker approach to address patents and medicines to ensure “universal access.” Discussions about patents and medicines in any forum appear to lead to the World […]